Bio-Rad Labs (BIO) Posts Q4 Loss of $0.70/Sh
Tweet
Share
E-mail
Get Alerts BIO Hot Sheet
Price: $377.33 +0.24%
Revenue Growth %: -0.4%
Financial Fact:
Other (income) expense, net: -11.21M
Today's EPS Names:
MLKN, KBH, WOR, More
Revenue Growth %: -0.4%
Financial Fact:
Other (income) expense, net: -11.21M
Today's EPS Names:
MLKN, KBH, WOR, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q4 EPS of ($0.70), which does not compare to the analyst estimate of $1.03. Revenue for the quarter came in at $571.5 million versus the consensus estimate of $570.1 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Morgan Stanley Upgrades Coal India Ltd (COAL:IN) to Overweight
- Jefferies Starts Oversea-Chinese Banking Corp Ltd (OCBC:SP) (OVCHF) at Hold
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
